CPOX
Basic information
Region (hg38): 3:98579446-98593648
Previous symbols: [ "CPO" ]
Links
Phenotypes
GenCC
Source:
- hereditary coproporphyria (Strong), mode of inheritance: AD
- hereditary coproporphyria (Strong), mode of inheritance: AR
- hereditary coproporphyria (Strong), mode of inheritance: AD
- harderoporphyria (Strong), mode of inheritance: AR
- hereditary coproporphyria (Strong), mode of inheritance: AR
- hereditary coproporphyria (Supportive), mode of inheritance: AD
- harderoporphyria (Limited), mode of inheritance: AR
- CPOX-related hereditary coproporphyria (Definitive), mode of inheritance: Semidominant
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Coproporphyria; Harderoporphyria | AD/AR | Hematologic; Pharmacogenomic | In Coprophyria, attacks may be precipitated by a variety of agents (eg, fasting, as well as specific pharmaceutical agents, including oral contraceptives), which should be avoided; IV therapy (with heme arginate) has been described as effective; In heterozygotes, specific considerations are important in surgery (eg, use of IV glucose perioperatively) and related to agent selection for anesthesia induction; Liver transplanation has been described; In Harderoporphyria, individuals may suffer from neonatal hemolytic anemia, which may necessitate RBC transfusions | Gastrointestinal; Hematologic; Neurologic | 14378650; 5838412; 4163920; 4393048; 74745; 6886003; 6502649; 6143037; 8012360; 8286403; 7757079; 11309681; 12227458; 12181641; 16151909; 16159891; 21103937; 23236641 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (202 variants)
- Hereditary_coproporphyria (49 variants)
- Inborn_genetic_diseases (36 variants)
- CPOX-related_disorder (16 variants)
- Coproporphyria (10 variants)
- Harderoporphyria (6 variants)
- CPOX-related_hereditary_coproporphyria (3 variants)
- not_specified (1 variants)
- COPROPORPHYRIA,_DIGENIC (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPOX gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000097.7. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 37 | 45 | ||||
| missense | 130 | 11 | 157 | |||
| nonsense | 8 | |||||
| start loss | 0 | |||||
| frameshift | 12 | 16 | ||||
| splice donor/acceptor (+/-2bp) | 5 | |||||
| Total | 26 | 13 | 136 | 48 | 8 |
Highest pathogenic variant AF is 0.00006443842
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CPOX | protein_coding | protein_coding | ENST00000264193 | 7 | 72592 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.172 | 0.828 | 125739 | 0 | 9 | 125748 | 0.0000358 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.35 | 173 | 231 | 0.750 | 0.0000119 | 2901 |
| Missense in Polyphen | 61 | 109.86 | 0.55527 | 1292 | ||
| Synonymous | -0.582 | 95 | 88.0 | 1.08 | 0.00000437 | 913 |
| Loss of Function | 3.03 | 5 | 19.4 | 0.258 | 9.11e-7 | 233 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000145 | 0.000145 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000352 | 0.0000352 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the heme biosynthesis. Catalyzes the aerobic oxidative decarboxylation of propionate groups of rings A and B of coproporphyrinogen-III to yield the vinyl groups in protoporphyrinogen-IX.;
- Disease
- DISEASE: Hereditary coproporphyria (HCP) [MIM:121300]: A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Hereditary coproporphyria is an acute hepatic porphyria characterized by skin photosensitivity, attacks of abdominal pain, neurological disturbances, and psychiatric symptoms. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors. Hereditary coproporphyria is biochemically characterized by overexcretion of coproporphyrin III in the urine and in the feces. {ECO:0000269|PubMed:12181641, ECO:0000269|PubMed:15896662, ECO:0000269|PubMed:16398658, ECO:0000269|PubMed:7757079, ECO:0000269|PubMed:7849704, ECO:0000269|PubMed:8012360, ECO:0000269|PubMed:8990017, ECO:0000269|PubMed:9048920, ECO:0000269|PubMed:9298818, ECO:0000269|PubMed:9888388}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Porphyrin and chlorophyll metabolism - Homo sapiens (human);Hereditary Coproporphyria (HCP);Porphyria Variegata (PV);Congenital Erythropoietic Porphyria (CEP) or Gunther Disease;Acute Intermittent Porphyria;Porphyrin Metabolism;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Heme Biosynthesis;hemoglobins chaperone;Heme biosynthesis;Metabolism of porphyrins;Metabolism;Porphyrin metabolism;Porphyrin metabolism;heme biosynthesis from uroporphyrinogen-III I;heme biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.146
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 76.96
Haploinsufficiency Scores
- pHI
- 0.543
- hipred
- N
- hipred_score
- 0.475
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.138
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cpox
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; immune system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- heme biosynthetic process;protoporphyrinogen IX biosynthetic process from glutamate;oxidation-reduction process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial intermembrane space;cytosol
- Molecular function
- coproporphyrinogen oxidase activity;protein homodimerization activity